Cannabinoid Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Phytocannabinoids, Endocannabinoids, Synthetics); Application (Medical, Recreational); Compound (THC-dominant, CBD-Dominant, Balanced THC and CBD)
Cannabinoid Drugs are natural occurring recreational drugs used to treat anorexia, chronic pain, and nausea & vomiting. The cannabinoid is used for a group of drugs that are structurally related to tetrahydro cannabinoids. It is manufactured by pharma companies to treat different indications, such as multiple chronic & acute migraine, sclerosis, seizures, rheumatoid arthritis, etc.
The Cannabinoid Drugs market is expected to grow significantly in the coming years, due to Rising demand for cannabinoid drugs for treating chronic pain in different indications. Moreover, healthcare expenditure in field of dermatology supported by FDA approvals anticipated to influence the end-user of Cannabinoid Drugs .
The "Cannabinoid Drugs Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Cannabinoid Drugs market with detailed market segmentation by, product type , application and compound. The Cannabinoid Drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Cannabinoid Drugs market and offers key trends and opportunities in the market.
The Cannabinoid Drugs market is segmented on the basis of product type , application and compound. Based on product type, the market is segmented into Phyto cannabinoids, Endocannabinoids, Synthetics. On the basis of application, the market is categorized as Medical, Recreational. On the basis of compound, the market is categorized as THC-dominant , CBD-Dominant, Balanced THC and CBD.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Cannabinoid Drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Cannabinoid Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cannabinoid drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Cannabinoid Drugs market in these regions.
Get more information on this report :
The report covers key developments in the Cannabinoid Drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Cannabinoid Drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for Cannabinoid Drugs in the global market. Below mentioned is the list of few companies engaged in the Cannabinoid Drugs market.
The report also includes the profiles of key players in Cannabinoid Drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Canopy Growth Corporation
Aurora Cannabis Inc.
Cannabis Science Inc.
Maricann Group Inc.
VIVO Cannabis Inc.
Medical Marijuana, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
The List of Companies
1. Canopy Growth Corporation
2. Aurora Cannabis Inc.
3. Tikun Olam
4. Cannabis Science Inc.
5. Aphria Inc.
6. Maricann Group Inc.
7. Tilray Inc.
8. VIVO Cannabis Inc.
9. Medical Marijuana, Inc.